![](https://investorshub.advfn.com/uicon/138434.png?cb=1464725830)
Monday, January 11, 2021 4:41:06 PM
Revive Therapeutics (RVVTF) will not publicly release the data on the interim analysis before it’s had a chance to be reviewed by the Independent Data and Safety Monitoring Board (DSMB).
Only after will RVVTF publicly release the data with the DSMB’s review and recommendations, which also may include RVVTF has started the process to file for an Emergency Use Authorization (EUA).
I'm like most here and was hoping for news in late December. Thus I am disappointed we are in mid January with no news yet. I am hoping for news this week but who knows if it will come. Any thought to the possibility of MF releasing the 210 data along with EUA approval or fda at the same time?
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM